FDA
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
-
-
-
-
-
-
-
Sanofi's Tzield gets expedited FDA review for stage 3 type 1 diabetes
-
-
-
-
-
-
-
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
-
-
-
-
-
-
-
Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing
-
-
-
-
-
-
-
FDA approves Sanofi’s (SNY) hemophilia treatment Qfitlia
-
-
-
-
-
-
-
Press Release: Sanofi and CD&R sign Opella share purchase agreement
-
-
-
-
-
-
-
Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

